Evidence map›Paper›PMID 9696809›Full record

ArticleJournal of virology1998

The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.

K Fujinaga, T P Cujec, J Peng, J Garriga, D H Price, X Graña, B M Peterlin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

K FujinagaDepartments of Medicine, Microbiology, and Immunology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California 94143-0703, USA.
T P Cujec
J Peng
J Garriga
D H Price
X Graña
B M Peterlin
Temple University · USUniversity of California, San Francisco · USUniversity of Iowa · USHoward Hughes Medical Institute · US

Funding

FACTORS INVOLVED IN TRANSCRIPTION BY RNA POLYMERSASE IIR01GM035500 · NIGMS · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 1985 to 2017
$6.5M
IN VITRO AND IN VIVO FUNCTION OF HIV AND SIV NEF GENESR01AI038532 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI LUCIW, PAUL A · 1995 to 2002
$1.8M
NIAID NIH HHS AI38532-01NIGMS NIH HHS GM35500NIGMS NIH HHS R01 GM035500
6 · The paper itself

Abstract

By binding to the transactivation response element (TAR) RNA, the transcriptional transactivator (Tat) from the human immunodeficiency virus increases rates of elongation rather than initiation of viral transcription. Two cyclin-dependent serine/threonine kinases, CDK7 and CDK9, which phosphorylate the C-terminal domain of RNA polymerase II, have been implicated in Tat transactivation in vivo and in vitro. In this report, we demonstrate that CDK9, which is the kinase component of the positive transcription elongation factor b (P-TEFb) complex, can activate viral transcription when tethered to the heterologous Rev response element RNA via the regulator of expression of virion proteins (Rev). The kinase activity of CDK9 and cyclin T1 is essential for these effects. Moreover, P-TEFb binds to TAR only in the presence of Tat. We conclude that Tat-P-TEFb complexes bind to TAR, where CDK9 modifies RNA polymerase II for the efficient copying of the viral genome.

Indexed as

Transcriptional ActivationCell Line, TransformedCyclin-Dependent KinasesCyclinsCyclin TGene Products, revGene Products, tatHeLa CellsHIV-1HIV Long Terminal RepeatHumansPeptide Elongation FactorsPositive Transcriptional Elongation Factor BProtein Serine-Threonine Kinasesrev Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency VirusCCNT1 protein, humanCyclin-Dependent KinasesCyclinsCyclin TGene Products, revGene Products, tatPeptide Elongation FactorsPositive Transcriptional Elongation Factor BProtein Serine-Threonine Kinasesrev Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID9696809
PMCPMC109937
OpenAlexW2102380059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.